BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 33068426)

  • 21. Impact of the Tumor Microenvironment for Esophageal Tumor Development-An Opportunity for Prevention?
    Borgmann M; Quante M
    Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytokine Interaction With Cancer-Associated Fibroblasts in Esophageal Cancer.
    Hassan MS; Cwidak N; Awasthi N; von Holzen U
    Cancer Control; 2022; 29():10732748221078470. PubMed ID: 35442094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Telomere shortening accelerates tumor initiation in the L2-IL1B mouse model of Barrett esophagus and emerges as a possible biomarker.
    Sahm V; Maurer C; Baumeister T; Anand A; Strangmann J; Schmid RM; Wang TC; Quante M
    Oncotarget; 2022; 13():347-359. PubMed ID: 35178191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor Microenvironment of Esophageal Cancer.
    Schiffmann LM; Plum PS; Fuchs HF; Babic B; Bruns CJ; Schmidt T
    Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Notch Signaling Mediates Differentiation in Barrett's Esophagus and Promotes Progression to Adenocarcinoma.
    Kunze B; Wein F; Fang HY; Anand A; Baumeister T; Strangmann J; Gerland S; Ingermann J; Münch NS; Wiethaler M; Sahm V; Hidalgo-Sastre A; Lange S; Lightdale CJ; Bokhari A; Falk GW; Friedman RA; Ginsberg GG; Iyer PG; Jin Z; Nakagawa H; Shawber CJ; Nguyen T; Raab WJ; Dalerba P; Rustgi AK; Sepulveda AR; Wang KK; Schmid RM; Wang TC; Abrams JA; Quante M
    Gastroenterology; 2020 Aug; 159(2):575-590. PubMed ID: 32325086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-Fat Diet Accelerates Carcinogenesis in a Mouse Model of Barrett's Esophagus via Interleukin 8 and Alterations to the Gut Microbiome.
    Münch NS; Fang HY; Ingermann J; Maurer HC; Anand A; Kellner V; Sahm V; Wiethaler M; Baumeister T; Wein F; Einwächter H; Bolze F; Klingenspor M; Haller D; Kavanagh M; Lysaght J; Friedman R; Dannenberg AJ; Pollak M; Holt PR; Muthupalani S; Fox JG; Whary MT; Lee Y; Ren TY; Elliot R; Fitzgerald R; Steiger K; Schmid RM; Wang TC; Quante M
    Gastroenterology; 2019 Aug; 157(2):492-506.e2. PubMed ID: 30998992
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Fang HY; Münch NS; Schottelius M; Ingermann J; Liu H; Schauer M; Stangl S; Multhoff G; Steiger K; Gerngroß C; Jesinghaus M; Weichert W; Kühl AA; Sepulveda AR; Wester HJ; Wang TC; Quante M
    Clin Cancer Res; 2018 Mar; 24(5):1048-1061. PubMed ID: 29208671
    [No Abstract]   [Full Text] [Related]  

  • 28. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
    O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
    Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterizing caspase-1 involvement during esophageal disease progression.
    Barber G; Anand A; Katarzyna Oficjalska ; Phelan JJ; Heeran AB; Flis E; Clarke NE; Watson JA; Strangmann J; Flood B; O'Neill H; O'Toole D; MacCarthy F; Ravi N; Reynolds JV; Kay EW; Quante M; O'Sullivan J; Creagh EM
    Cancer Immunol Immunother; 2020 Dec; 69(12):2635-2649. PubMed ID: 32613271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elimination of NF-κB signaling in Vimentin+ stromal cells attenuates tumorigenesis in a mouse model of Barrett's Esophagus.
    Anand A; Fang HY; Mohammad-Shahi D; Ingermann J; Baumeister T; Strangmann J; Schmid RM; Wang TC; Quante M
    Carcinogenesis; 2021 Apr; 42(3):405-413. PubMed ID: 33068426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Barrett's esophagus: cancer and molecular biology.
    Gibson MK; Dhaliwal AS; Clemons NJ; Phillips WA; Dvorak K; Tong D; Law S; Pirchi ED; Räsänen J; Krasna MJ; Parikh K; Krishnadath KK; Chen Y; Griffiths L; Colleypriest BJ; Farrant JM; Tosh D; Das KM; Bajpai M
    Ann N Y Acad Sci; 2013 Oct; 1300():296-314. PubMed ID: 24117650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The diagnosis and management of Barrett's esophagus.
    DeMeester SR; DeMeester TR
    Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Effect of Proton Pump Inhibitors on Barrett's Esophagus.
    Dunbar KB; Souza RF; Spechler SJ
    Gastroenterol Clin North Am; 2015 Jun; 44(2):415-24. PubMed ID: 26021202
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.